LPIN3
Basic information
Region (hg38): 20:41340821-41360582
Previous symbols: [ "LIPN3L" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LPIN3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 42 | 46 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 43 | 8 | 1 |
Variants in LPIN3
This is a list of pathogenic ClinVar variants found in the LPIN3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-41345827-G-A | Likely benign (Mar 01, 2023) | |||
20-41345862-G-A | Benign (Mar 29, 2018) | |||
20-41345887-C-G | not specified | Uncertain significance (Mar 20, 2024) | ||
20-41345900-G-A | not specified | Uncertain significance (Jul 14, 2022) | ||
20-41345944-C-G | Likely benign (Aug 01, 2022) | |||
20-41345951-G-C | not specified | Uncertain significance (Nov 06, 2023) | ||
20-41345955-G-A | not specified | Uncertain significance (Mar 18, 2024) | ||
20-41345972-G-A | not specified | Uncertain significance (Aug 08, 2022) | ||
20-41347616-C-A | not specified | Uncertain significance (Dec 15, 2022) | ||
20-41348661-G-C | not specified | Uncertain significance (Feb 17, 2023) | ||
20-41348724-G-A | not specified | Uncertain significance (Aug 14, 2023) | ||
20-41348737-C-T | not specified | Likely benign (Oct 17, 2023) | ||
20-41348749-GGCGGAGGAAGAGGC-G | Uncertain significance (Aug 01, 2022) | |||
20-41348762-G-C | not specified | Uncertain significance (Mar 31, 2024) | ||
20-41348764-G-A | not specified | Uncertain significance (Jun 29, 2023) | ||
20-41348767-G-A | not specified | Uncertain significance (May 17, 2023) | ||
20-41348767-G-T | not specified | Uncertain significance (Nov 14, 2023) | ||
20-41349092-T-C | Likely benign (Aug 01, 2022) | |||
20-41349799-C-T | not specified | Uncertain significance (Jan 19, 2022) | ||
20-41349818-T-C | not specified | Uncertain significance (Oct 06, 2023) | ||
20-41349827-G-A | not specified | Uncertain significance (Dec 13, 2023) | ||
20-41349833-C-T | not specified | Uncertain significance (May 29, 2024) | ||
20-41350080-C-T | not specified | Uncertain significance (May 20, 2024) | ||
20-41350125-G-C | not specified | Uncertain significance (Feb 27, 2023) | ||
20-41350139-A-C | not specified | Uncertain significance (Nov 07, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LPIN3 | protein_coding | protein_coding | ENST00000373257 | 19 | 19663 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.25e-13 | 0.955 | 125313 | 1 | 434 | 125748 | 0.00173 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.652 | 466 | 507 | 0.919 | 0.0000302 | 5477 |
Missense in Polyphen | 132 | 156.34 | 0.84429 | 1662 | ||
Synonymous | 1.03 | 196 | 215 | 0.910 | 0.0000133 | 1755 |
Loss of Function | 2.24 | 27 | 42.9 | 0.630 | 0.00000211 | 480 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00783 | 0.00780 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000435 | 0.000435 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.00134 | 0.00132 |
Middle Eastern | 0.000435 | 0.000435 |
South Asian | 0.00131 | 0.00118 |
Other | 0.00197 | 0.00196 |
dbNSFP
Source:
- Function
- FUNCTION: Regulates fatty acid metabolism. Magnesium-dependent phosphatidate phosphatase enzyme which catalyzes the conversion of phosphatidic acid to diacylglycerol during triglyceride, phosphatidylcholine and phosphatidylethanolamine biosynthesis (By similarity). {ECO:0000250}.;
- Pathway
- Glycerolipid metabolism - Homo sapiens (human);Glycerophospholipid metabolism - Homo sapiens (human);Adipogenesis;Metabolism of lipids;Metabolism;Synthesis of PC;Synthesis of PE;Triglyceride biosynthesis;Triglyceride metabolism;Depolymerisation of the Nuclear Lamina;Nuclear Envelope Breakdown;Mitotic Prophase;Glycerophospholipid biosynthesis;Phospholipid metabolism;M Phase;Cell Cycle;Cell Cycle, Mitotic
(Consensus)
Recessive Scores
- pRec
- 0.106
Intolerance Scores
- loftool
- 0.431
- rvis_EVS
- 0.56
- rvis_percentile_EVS
- 81.72
Haploinsufficiency Scores
- pHI
- 0.147
- hipred
- N
- hipred_score
- 0.234
- ghis
- 0.553
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.511
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | High | Medium | High |
Mouse Genome Informatics
- Gene name
- Lpin3
- Phenotype
- immune system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- phosphatidylethanolamine biosynthetic process;phosphatidylcholine biosynthetic process;fatty acid catabolic process;dephosphorylation;triglyceride biosynthetic process;cellular response to insulin stimulus;positive regulation of transcription by RNA polymerase II
- Cellular component
- nucleus;endoplasmic reticulum membrane
- Molecular function
- transcription coactivator activity;phosphatidate phosphatase activity